361 Capital’s MiMedx Group MDXG Stock Holding History

361 Capital’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-114,926	Closed	-$1.45M	–	310
2017 Q4	$1.45M	Buy	+114,926	New	+$1.4M	0.36%	144

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

361 Capital's MDXG Position: Q1 2018 in Review

361 Capital sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 114,926 shares — an estimated $1.45M sold.

361 Capital first reported a position in MDXG in Q4 2017 and held it in 1 quarter. The position peaked at $1.45M in Q4 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

361 Capital reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
361 Capital sold 114,926 MiMedx Group shares in Q1 2018, an estimated $1.45M.
361 Capital first reported a position in MiMedx Group in Q4 2017 and held it in 1 quarter.
361 Capital's MiMedx Group position peaked at $1.45M in Q4 2017.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.